AzTrials
AzTrials

StrokeNCT07898657

Effect of an Electromagnetic Trainer on Gait and Balance Recovery After Stroke

A study testing Electromagnetic trainer and Standard medical rehabilitation in people with Stroke, run by Karaganda Medical University at 2 sites in Kazakhstan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to evaluate the effectiveness of an electromagnetic trainer in improving lower limb motor function, gait, and balance in patients after cerebral stroke. The study will include 80 adult patients with a first-ever cerebral stroke who are undergoing medical rehabilitation. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Stroke
What is being tested?
Electromagnetic trainer and Standard medical rehabilitation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
2 sitesKazakhstan
Study dates
12 May 2026to Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • First-ever confirmed cerebral stroke.
  • Adults aged 18 to 75 years.
  • Acute or early subacute period after stroke following early verticalization.
  • Clear consciousness.
  • Presence of lower-limb motor impairment.
  • MMSE score ≥25.
Show all 9Show fewer
  • No rheumatologic conditions, including contractures or severe pain that may interfere with rehabilitation.
  • No acute or decompensated chronic internal diseases.
  • Provision of written informed consent to participate in the study.

Who cannot join

  • Impaired or unclear consciousness.
  • Recurrent stroke.
  • Absence of lower-limb motor impairment.
  • Cognitive impairment (MMSE <25).
  • Rheumatologic conditions, including contractures or severe pain that may interfere with rehabilitation.
  • Acute or decompensated chronic internal diseases.
  • Refusal to participate or withdrawal of informed consent.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Inna A Bolshakova contact

+77773512504

I.Malysheva@qmu.kz

Kazakhstan2 sites, 2 recruiting
  • Akzhan Clinic

    Karaganda, Qaraghandy Oblysy

    Inna Bolshakova, +77773512504, I.Malysheva@qmu.kz

    Inna A Bolshakova

    Recruiting
  • Multidisciplinary Hospital named after Professor H. Zh. Makazhanov

    Karaganda, Qaraghandy Oblysy

    Inna Bolshakova, +77773512504, I.Malysheva@qmu.kz

    Inna Bolshakova

    Recruiting

Other trials in Kazakhstan

About this study

Official title: Evaluation of the Effectiveness of an Electromagnetic Trainer in Restoring Gait and Balance in Patients After Cerebral Stroke

This study aims to evaluate the effectiveness of an electromagnetic trainer in improving lower limb motor function, gait, and balance in patients after cerebral stroke. The study will include 80 adult patients with a first-ever cerebral stroke who are undergoing medical rehabilitation. Participants will be randomly allocated to two parallel groups. The control group will receive standard medical rehabilitation, while the intervention group will receive standard rehabilitation combined with motor training using an electromagnetic trainer. Clinical and functional assessments will include neurological status, functional independence, gait and balance, lower limb motor function, muscle tone, range of motion, and psycho-emotional status. The study is expected to determine whether the addition of electromagnetic motor training provides greater improvement in functional outcomes compared with standard rehabilitation alone.

Conditions
Stroke
Being tested
Electromagnetic trainer, Standard medical rehabilitation
Keywords
Stroke rehabilitation, Electromechanical rehabilitation device, Lower limb motor function, Balance, Gait
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Electromagnetic trainerDevice

    Motor training using an electromagnetic trainer to improve lower limb motor function, gait, and balance after cerebral stroke. The intervention is provided in addition to standard medical rehabilitation.

  • Standard medical rehabilitationOther

    • Standard medical rehabilitation provided to participants after cerebral stroke according to the clinical rehabilitation program.
Study groups in NCT07898657
Study groupRoleWhat they receive
standart rehabilitation aloneActive comparatorParticipants will receive standard medical rehabilitation after stroke.
Receives: Other: Standard medical rehabilitation
standart rehabilitation plus trainerExperimentalParticipants will receive standard medical rehabilitation combined with motor training using an electromagnetic trainer.
Receives: Device: Electromagnetic trainer; Other: Standard medical rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Berg Balance Scale (BBS)

    Change in Berg Balance Scale (BBS) score from baseline to the end of rehabilitation. The BBS ranges from 0 to 56 points, with higher scores indicating better balance.

    Measured: From baseline to the end of the rehabilitation course (approximately 10 days).

Secondary outcomes (7)
  1. Change in Tinetti Performance-Oriented Mobility Assessment (POMA) score from baseline to the end of rehabilitation

    Change in Tinetti Performance-Oriented Mobility Assessment (POMA) score from baseline to the end of rehabilitation. The total score ranges from 0 to 28 points, with higher scores indicating better gait and balance performance.

    Measured: Baseline to end of rehabilitation (approximately 10 days)

  2. Change in Timed Up and Go (TUG) test time from baseline to the end of rehabilitation

    Change in the time required to complete the Timed Up and Go (TUG) test from baseline to the end of rehabilitation. Time is measured in seconds; lower times indicate better functional mobility.

    Measured: Baseline to end of rehabilitation (approximately 10 days)

  3. Fugl-Meyer Assessment - Lower Extremity, Section E (0-28 points)

    Change in lower-extremity motor function assessed using Section E of the Fugl-Meyer Assessment. The score ranges from 0 to 28 points, with higher scores indicating better motor function.

    Measured: Baseline to end of rehabilitation (approximately 10 days)

  4. Change in National Institutes of Health Stroke Scale (NIHSS) score from baseline to the end of rehabilitation

    Change in neurological impairment assessed using the National Institutes of Health Stroke Scale (NIHSS) from baseline to the end of rehabilitation. The total score ranges from 0 to 42 points, with higher scores indicating more severe neurological impairment.

    Measured: Baseline to end of rehabilitation (approximately 10 days)

  5. Change in Modified Ashworth Scale score from baseline to the end of rehabilitation

    Change in muscle tone assessed using the Modified Ashworth Scale (MAS) from baseline to the end of rehabilitation. The scale grades resistance to passive movement from 0 to 4, with an additional grade of 1+, where applicable. Higher grades indicate greater muscle tone and spasticity.

    Measured: At rehabilitation admission (baseline) and at discharge from rehabilitation (approximately 10 days after baseline).

  6. Change in Hospital Anxiety and Depression Scale (HADS) score from baseline to the end of rehabilitation

    Change in anxiety and depressive symptoms assessed using the Hospital Anxiety and Depression Scale (HADS) from baseline to the end of rehabilitation. The scale consists of two subscales: anxiety (HADS-A) and depression (HADS-D), each ranging from 0 to 21 points. Higher scores indicate greater severity of anxiety or depressive symptoms.

    Measured: Baseline to end of rehabilitation (approximately 10 days)

  7. Change in Barthel Index score from baseline to the end of rehabilitation

    Change in functional independence assessed using the Barthel Index from baseline to the end of rehabilitation. The total score ranges from 0 to 100 points, with higher scores indicating greater independence in activities of daily living.

    Measured: Baseline to end of rehabilitation (approximately 10 days)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Oct 2026
  2. Study start12 May 2026
  3. Primary completionAug 2027 (estimated)
  4. Study completionAug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07898657
Sponsor's protocol ID
EMT-STROKE
Status last verified
Oct 2026
First submitted
5 Oct 2026
Last updated
27 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Electromagnetic trainer and Standard medical rehabilitation in people with Stroke, run by Karaganda Medical University at 2 sites in Kazakhstan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Kazakhstan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Inna A Bolshakova (+77773512504, I.Malysheva@qmu.kz), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Berg Balance Scale (BBS) (time frame: From baseline to the end of the rehabilitation course (approximately 10 days).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in